Albert Einstein College of Medicine Hematology and Medical Oncology

Topics

• Nausea and vomiting management 102
• Multiple Myeloma Research and Treatments 96
• Lung Cancer Treatments and Mutations 40
• Cancer Treatment and Pharmacology 22
• CAR-T cell therapy research 18
• Acute Myeloid Leukemia Research 14
• Cancer survivorship and care 14
• Lung Cancer Research Studies 14
• Lung Cancer Diagnosis and Treatment 12
• Cancer Immunotherapy and Biomarkers 11
• Chronic Lymphocytic Leukemia Research 8
• Amyloidosis: Diagnosis, Treatment, Outcomes 6

Most cited

1. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.

   The New England journal of medicine · 2023 · 479 citations · Jean Bustamante-Alvarez

2. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

   JAMA oncology · 2023 · 399 citations · Oleg Gligich

3. Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study.

   The Lancet. Haematology · 2025 · 93 citations · Carolina Schinke

4. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.

   ESMO open · 2024 · 128 citations · Richard Gralla

5. Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

   Blood cancer journal · 2024 · 95 citations · Carolina Schinke

6. Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.

   Blood advances · 2023 · 131 citations · Carolina Schinke